LifeStance Health (LFST) Gross Profit (2020 - 2024)

LifeStance Health (LFST) has 5 years of Gross Profit data on file, last reported at $100.4 million in Q3 2024.

• Quarterly Gross Profit rose 31.78% year-over-year to $100.4 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $376.3 million (up 33.68% YoY) and the FY2023 annual result came in at $302.1 million, up 27.46% from the prior year.
• Gross Profit climbed to $100.4 million in Q3 2024 per LFST's latest filing, from $97.8 million in the prior quarter.
• Across five years, Gross Profit topped out at $100.4 million in Q3 2024 and bottomed at $14.2 million in Q2 2020.
• The 5-year median for Gross Profit is $60.3 million (2022), against an average of $63.6 million.
• The widest annual swing landed in 2021, when Gross Profit surged 261.18%; it then climbed 15.56% in 2022.
• Tracing LFST's Gross Profit over 5 years: stood at $33.1 million in 2020, then jumped by 63.72% to $54.2 million in 2021, then rose by 15.56% to $62.7 million in 2022, then soared by 32.89% to $83.3 million in 2023, then increased by 20.55% to $100.4 million in 2024.
• Per Business Quant, the three latest LFST Gross Profit figures stand at $100.4 million (Q3 2024), $97.8 million (Q2 2024), and $94.7 million (Q1 2024).

Peer Comparison